Back to Top Skip to main content

Measles vaccine protects against potentially serious illness

A Salvadoran nurse vaccinates a baby during a Task Force Northstar mission in El Salvador to provide medical care and other humanitarian and civic assistance. The mission involved U.S. military personnel working alongside their Brazilian, Canadian, Chilean, and Salvadoran counterparts. (U.S. Army Photo by Sgt. Kim Browne) A Salvadoran nurse vaccinates a baby during a Task Force Northstar mission in El Salvador to provide medical care and other humanitarian and civic assistance. The mission involved U.S. military personnel working alongside their Brazilian, Canadian, Chilean, and Salvadoran counterparts. (U.S. Army Photo by Sgt. Kim Browne)

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Recommendations | Children's Health

In the midst of a measles outbreak in the United States, public health officials are urging parents to get their children vaccinated, and for parents to make sure they're up to date on their own vaccinations.

As of March 28, there have been 387 confirmed cases of the potentially serious illness this year, according to the Centers for Disease Control and Prevention. In Rockland County, New York, officials announced a temporary ban on unvaccinated people gathering in enclosed public spaces, reporting that more than 80 percent of the individuals with measles had not been vaccinated.

Measles is a highly contagious virus that lives in the nose and throat mucus of an infected person. The virus, which is spread by air when an infected person breathes, coughs, or sneezes, can remain in the air for up to two hours after the infected individual leaves.

The vaccine to protect against measles is called the MMR vaccine because it also protects against mumps and rubella. Two doses of the vaccine are recommended, said Dr. Margaret Ryan, a retired Navy captain and the medical director of the Pacific Region Vaccine Safety Hub of the Defense Health Agency's Immunization Healthcare Branch.

According to the CDC, two doses of the MMR vaccine are about 97 percent effective in preventing measles, and one dose is about 93 percent effective.

"The MMR vaccine is a requirement for joining the service," Ryan said. "And all military family members should get the MMR vaccine along with other vaccines recommended by public health authorities such as the CDC. We strongly encourage and support protecting beneficiaries this way."

Noting that the DHA follows CDC recommendations, Ryan said children should get the first dose of the MMR vaccine at age 12 to 15 months. The second dose follows at least 28 days later, but usually between the ages of 4 and 6.

Adults who didn't receive two vaccine doses in childhood should also get at least one dose, she said.

"Those who are uncertain of their childhood vaccination history can get a blood test to confirm they're protected, or get the MMR vaccine," Ryan said. "Generally, it's safe to get extra doses."

The MMR vaccine is especially important for those who are traveling overseas. According to the World Health Organization, while deaths from measles have decreased significantly in recent years, the illness remains common, particularly in developing countries. According to the CDC, many of the recent U.S. cases of measles have been linked to visits to Israel, Ukraine, and other countries where large outbreaks have occurred.

People who should not get the vaccine include those who are pregnant, immune-compromised, or allergic to a component of the MMR vaccine, Ryan said. According to the CDC, allergic reactions are rare – about 1 in a million doses – and would occur anywhere from a few minutes to a few hours after the vaccination.

Some parents mistakenly believe the MMR vaccine is connected to autism spectrum disorders. However, a large body of scientific research has proven there is no link between vaccines and the developmental disorder, even in children at high risk.

While most people don't experience side effects from receiving the MMR vaccine, some may get a mild fever or redness, swelling, or pain at the injection site, Ryan said.

"These kinds of symptoms are less common after the second dose," she said, "and if they occur, they usually resolve over a few days."

Coming down with measles is uncomfortable at best. The illness causes a rash and high fever. Further, approximately 30 percent of measles patients have complications including pneumonia or encephalitis, which is inflammation of the brain. Ryan said about 1 in every 500 people who contract measles dies of the infection.

CDC data showed 372 cases in the civilian population in 2018. In 2017, there were no confirmed measles cases in the Military Health System, compared with 120 in the civilian population. The October 2017 Medical Surveillance Monthly Report includes data from 2010 to 2016 and can be accessed here.

You also may be interested in...

III MEF Force Health Protection Requirements 2019

Policy

Report on Plan to Improve Pediatric Care and Related Services for Children of Members of the Armed Forces

Congressional Testimony
12/26/2018

HR 2810, NDAA Conference Report for FY 2018, Sec 733

Recommended Content:

Children's Health

Vaccination is the best defense against the flu

Article
12/10/2018
Vaccination is the primary method for preventing influenza and its complications and getting an annual influenza vaccine is the best way to protect yourself and your family from the flu. (U.S. Army photo by Staff Sgt. Erica Knight)

Vaccination is needed every year because the Influenza viruses change

Recommended Content:

Health Readiness | Immunization Healthcare | Immunizations

Global Routine Vaccination Coverage — 2017

Report
11/16/2018

Global coverage with vaccines to prevent diphtheria, tetanus, pertussis, polio, and measles has remained at 84%–85% since 2010. Prioritizing countries with the highest number of unvaccinated children to implement context-specific strategies has the potential to increase immunization coverage globally.

Recommended Content:

Immunization Healthcare | Measles-Mumps-Rubella | Polio | Tetanus-Diphtheria-Pertussis

Updated Framework for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices

Report
11/16/2018

In 2010, the Advisory Committee on Immunization Practices (ACIP) implemented the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach for developing evidence-based recommendations. Since its February 2018 meeting, ACIP has incorporated the use of Evidence to Decision or Evidence to Recommendation (EtR) frameworks into GRADE methodology.

Recommended Content:

Immunization Healthcare | Vaccine Recommendations

MILPERSMAN 1730-020 Immunization Exemptions for Religious Beliefs

Policy

Process for requesting immunization exemptions, pursuant to the Navy Military Personnel Manual.

Vaccination Coverage Among Children Aged 19–35 Months — United States, 2017

Report
10/12/2018

The Advisory Committee on Immunization Practices recommends routine vaccination by age 24 months against 14 potentially serious illnesses. In 2017, coverage with most recommended vaccines among children aged 19–35 months remained stable and high but was lower in more rural areas and among uninsured or Medicaid-insured children.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Schedules

Vaccination Coverage for Selected Vaccines and Exemption Rates Among Children in Kindergarten — United States, 2017–18 School Year

Report
10/12/2018

Immunization programs conduct annual kindergarten vaccination assessments to monitor school-entry vaccination coverage for all state-required vaccines. Median vaccination coverage was 94.3% for 2 doses of measles, mumps, and rubella vaccine; 95.1% for the state-required number of doses of diphtheria and tetanus toxoids and acellular pertussis vaccine; and 93.8% for 2 doses of varicella vaccine.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Vaccine Schedules

Vaccination Coverage Among Children Aged 2 Years — U.S. Affiliated Pacific Islands, April–October, 2016

Report
5/25/2018

A new method of estimating vaccine coverage by medical record abstraction in the remote U.S. Affiliated Pacific Islands showed coverage with the combined six-vaccine series by age 2 years ranged from 19.5% to 69.1%.

Recommended Content:

Vaccine-Preventable Diseases | Vaccine Recommendations

Month of the Military Child - Eli

Video
4/24/2018
Month of the Military Child - Eli

In recognition of Month of the Military Child, listen to 14-year-old Army military kid Eli share advice about how to cope with a parent’s deployment.

Recommended Content:

Children's Health

Month of the Military Child - Ava

Video
4/17/2018
Month of the Military Child - Ava

“I would tell other Military Kids to not worry and just be excited to see their parent once again.” Check out how Ava, a U.S. Army kid, counts down the days to her dad’s return from deployment.

Recommended Content:

Children's Health

Month of the Military Child - Joe

Video
4/10/2018
Month of the Military Child - Joe

Joe, a Coast Guard #MilKid, talks about how moving is like a rollercoaster. “One thing to consider is that you’ll still have your family with you. You’re always going to be with someone, and that’s what matters.”

Recommended Content:

Children's Health

2018 Month of the Military Child - Grace

Video
4/4/2018
2018 Month of the Military Child - Grace

In celebration of Month of the Military Child, 13-year-old Grace talks about moving and how she finds opportunities to remember the good things about where she'd lived before.

Recommended Content:

Children's Health

Immunization University Certificate Retrieval Instructions

Publication
2/14/2018

This document provides instructions for students to retrieve their certificates for Immunization University courses

Recommended Content:

Immunization Healthcare

Department of Defense Global, Laboratory-based Influenza Surveillance Program’s Influenza vaccine effectiveness estimates and surveillance trends, 2016 – 2017 Influenza Season

Infographic
2/5/2018
Each year, the Department of Defense (DoD) Global, Laboratory-based Influenza Surveillance Program performs surveillance for influenza among service members of the DoD and their dependent family members. In addition to routine surveillance, vaccine effectiveness (VE) studies are performed and results are shared with the Food and Drug Administration, Centers for Disease Control and Prevention, and the World Health Organization for vaccine evaluation. This report documents the annual surveillance trends for the 2016 – 2017 influenza season and the end-of-season VE results. The analysis was performed by the U.S. Air Force School of Aerospace Medicine Epidemiology Laboratory, and the DoD Influenza Surveillance Program staff at Wright-Patterson Air Force Base, OH. FINDINGS: A total of 5,555 specimens were tested from 84 locations: •	2,486 (44.7%) negative •	1,382 (24.9%) influenza A •	1,093 (19.7%) other respiratory pathogens •	443 (8.0%) influenza B •	151 (2.7%) co-infections The predominant influenza strain was A (H3N2), representing 73.8% of all circulating influenza. Pie chart displays this information. Graph showing the numbers and percentages of respiratory specimens positive for influenza viruses, and numbers of influenza viruses identified, by type, by surveillance week, Department of Defense healthcare beneficiaries, 2016 – 2017 influenza season displays. The vaccine effectiveness (VE) for this season was slightly lower than for the 2015 – 2016 season, which had a 63% (95% confidence interval: 53% - 71%) adjusted VE. The adjusted VE for the 2016 – 2017 season was 48% protective against all types of influenza.  Access the full report in the January 2018 MSMR (Vol. 25, No. 1). Go to: www.Health.mil/MSMR

This infographic documents the annual surveillance trends for the 2016 – 2017 influenza season and the end-of-season vaccine effectiveness.

Recommended Content:

Health Readiness | Influenza Summary and Reports | Medical Surveillance Monthly Report | Vaccine-Preventable Diseases | Force Health Protection | Global Health Engagement
<< < 1 2 3 4 5  ... > >> 
Showing results 61 - 75 Page 5 of 10

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.